IN 1975 Lukes and Tindle described 32 patients with lymphadenopathy histologically characterized by a proliferation of arborizing small vessels, prominent immunoblastic hyperplasia and amorphous acidophilic, PAS+, interstitial material. They designated this condition as immunoblastic lymphadenopathy, and proposed that it developed as a non-neoplastic hyperimmune proliferation of the B-cell system, involving an exaggeration of lymphocyte transformation to lymphoblasts and plasma cells, triggered by an abnormal hypersensitivity response to therapeutic agents. In 3 of their patients the process evolved into an immunoblastic sarcoma. Frizzera et al. (1975) described 24 patients with a syndrome characterized clinically by severe constitutional symptoms, generalized lymphadenopathy, hepatosplenomegaly and polyclonal hypergammaglobulinaemia and with histopathological features similar to those described by Lukes and Tindle. They designated this condition as angioimmunoblastic lymphadenopathy with dysproteinaemia (AILD) and proposed that the Reprint requests to Professor D. H. Wright. various manifestations of this conidition are consistent with an autoimmune disorder in which a deficiency of the T-cell regulatory function predisposes to an abnormal proliferation of autoaggressive B lymphocytes. None of their patients progressed to lymphoma. It is probably that this entity is the same as that described by Lukes and Tindle, or at least that there is a considerable overlap in the 2 series.
We have recently seen 8 patients with angioimmunoblastic lymphadenopathy and have been able to undertake immunological studies on fresh lymphnode material from 5 of these. The results presented reveal an immunological heterogeneity correlated with histological features, reflecting either the evolution of the disease with time or the inclusion of spectrum of reactivities in this condition.
MATERIALS AND METHODS
Patients.-Seven of the patients were seen in hospitals in the Southampton District during the period 1973-77 and diagnosed on routine lymphnode biopsy for the investiga-11 Ficoll-Triosil (Thorshy and Bratilie, 1970) . Cells collected at the interface were washed x 3 in cold medium and the final pellet resuspended at 2 x 106 cells/ml in HEPES-buffered medium for cellsurface marker-studies. Peripheral-blood lymphocytes were similarly prepared from venous blood by centrifugation through Ficoll-Triosil.
Rosette tests. Viable mononuclear cell preparations were examined for T lymphocytes by spontaneous sheep-cell rosetting, and for the presence of receptors for C3 and the Fc portion of Ig by rosetting with appropriately sensitized ox red blood cells. Cell suspensions AN-ere further stained with a polyvalent rabbit antiserum to human immunoglobulin heavy chains and to K and A light chains. Full details of these tests have been published previously (Payne et al., 1976 (b) Serunt studies A polyclonal elevation in serum immunoglobulin was observed in 3 patients (ID, RM, JP) an increase not confined to any single immunoglobulin class (Table II) . In all patients serum immunoglobulin levels declined with advancing disease.
Urinary paraproteins were not detected in any of the 8 patients studied. Autoantibody activity; directed to thryoid microsomes was detected in only one 10( f54 19-8* 4-6* 0-60 Marker studies performed on fresh biopsy material correlated with the histological appearance of the lymph nodes (Table III) . Patients with a high ratio of T to B cells or T-and B-cell depletion (ID, HK, RF) showed prominent arborising blood vessels, numerous eosinophils, blast cell proliferation but few plasmablasts or plasma cells ( Fig. 1 and 2) whereas patients with a high B/T ratio (RM, JP)
showed marked plasma-cell and plasmablast proliferation but few or no eosinophils (Fig. 3, 4 , 5 and 6).
(d) Immunoperoxidase
The immunoperoxidase findings paralleled the histological appearances and marker studies (Table III) similar to that seen in some germinal follicles, but in these instances not associated with recognizable residual follicles (Fig. 7) .
(e) Karyotypic studies In 3 patients (ID, FP, RF) where satisfactory cell preparations were obtained, abnormal cell clones were observed (Table IV) . No consistent chromosomal abnormality was identified. In one patient (RF) an abnormal population identified Electron-microscopic studies supported the light-microscopic findings but otherwise contributed nothing. Virus particles or other abnormal inclusions were not seen in any of the cases studied.
(g) Clinical correlations
This series of patients exhibited no common clinical features prior to the identification of lymphadenopathy; one patient had a tooth abscess, one a "flulike" illness, one had serological evidence of a recent cytomegalovirus infection and 3 were receiving a variety of drugs shortly before the onset of their disease.
Six of the patients have died, 5 within 13 months on onset and one after 40 :x;~~a~t: Fig. 8 and 9 ). The 2 patients with T-cell predominance both had a stormy fluctuating clinical course, with death from infection at 10 and 13 months post presentation. The 2 cases from whom viable biopsy material was not available for marker studies, both showed a histological pattern associated with B-cell predominance, and both are alive at 4 and 5 years after presentation. The post mortem findings are presented in Table V .
DISCUSSION
It is probable that, before 1975 when Lukes and Tindle and Frizzera et al., described the condition now recognized as angioimmunoblastic lymphadenopathy, most of these patients were diagnosed as Hodgkin's disease. Lukes and Tindle suggested that AIL may be induced by therapeutic agents, and it is possible that we are witnessing a new disease or a greatly increased incidence of AIL. In this series we have been unable to identify any therapeutic agent common to all the patients. Frizzera et al. (1974; 1975) have argued that AIL can be separated from malignant lymphoma by the polymorphic nature of the lesion, the absence of pleomorphism, and the fact that visceral masses and diffuse organ infiltrates are not seen in patients at post mortem. We would stress the widespread nature of the lymphadenopathy, often with enormous enlargement of all lymphnode groups, the often explosive onset of the disease, and the rapid fluctuations of the lymphadenopathy, as features that are unusual in most D. B. JONES ET AL. malignant lymphomas. However, the clinical picture is clearly not in itself diagnostic and laboratory confirmation is required.
Polyclonal hypergammaglobulinaemia present in 17/22 cases described by Frizzera et al. (1974) was found in only 3/6 patients in this series. We noted a substantial fall in the serum Ig in all patients with disease progression, suggesting that the inconstancy of this feature may be related to the duration and stage of the disease at presentation. The definitive diagnosis of AIL depends upon histological examination of involved lymphoid tissue. Lukes and Tindle (1975) * ' t , o ' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . cellular PAS+ material. The latter was an inconstant finding in this series (Table IV) and was abundant in only 6/24 patients reported by Frizzera et al. (1975) . Palutke et al. (1976) identified this material in electron micrographs as necrotic cell debris. It is perhaps not surprising, therefore, that this is a variable feature.
Vascular proliferation is a feature of lymph nodes in infectious mononucleosis (Carter and Penman, 1969) post-vaccinial lymphadenitis (Hartsock, 1968) congenital rubella (Krueger and Konorza, 1977) and in many lymphnodes showing nonspecific reactive hyperplasia. In AIL the arborizing nature of the vascular proliferation (Fig. 5) is usually much more evident than in these reactive and infective conditions, and is associated with total or almost complete effacement of the normal 1060 nodal architecture. In this series of patients, arborizing bolod vessels were least well developed in patients with B-cell predominance. Sidky and Aurbach (1975) described vascular proliferation as a measure of immune reactivity to autoantigens, and it would seem reasonable to propose that T-cell reactivity is responsible for the vessel proliferation seen in AIL. Palutke et al. (1976) described tubular inclusion in endothelial cells and lymphocytes from one patient with AIL studied by electron microscopy. We have not seen virus-like inclusions in any of the 4 cases studied by direct electron-microscopy, nor in endothelial cells from a 3-week culture of tissue from one case (ID).
We used marker techniques to study the lymphoid cells in AIL. Within this small group of patients, lymphocyte marker studies indicate a marked heterogeneity in lymphnode populations that correlates with the immunoperoxidase studies and the histological appearances, and may have prognostic significance. Relative Bcell predominance is accompanied histologically by plasmablast and plasma-cell proliferation, a picture that in this series was indicative of a relatively good prognosis. Patients with blast-cell proliferation, abundant eosinophils but few plasma cells, the histological picture associated with T-cell predominance or B-and T-cell depletion, had a poorer prognosis. We did not observe transition from B-cell predominance to T-cell predominance in any of the patients, suggesting that these are not separate phases within a single disease spectrum.
The association of relative B-cell predominance, as shown by marker studies, with plasma-cell proliferation, was confirmed by the immunoperoxidase studies, which showed numerous plasma cells and plasmablasts of all classes in these patients. Many fewer immunoglobulin-containing cells were seen in the T-cell predominant or T-and B-cell depleted groups. We are uncertain of the significance of the patchy reticular distribution of IgE and both lightchain classes in 3 of the cases (Fig. 7) . A similar pattern is seen in some germinal follicles of reactive lymphnodes, and was first described by Tada and Ishizaka (1970) using fluorescein-conjugated antisera. In the patients with AIL there were no residual follicles recognizable in the areas showing this IgE staining. In addition to large numbers of eosinophils, in some cases the immunoperoxidase stain for muramidase also showed large numbers of histiocytes (Fig. 10) . The number of histiocytes did not appear to differ significantly between the 2 groups. Many had a rounded cell outline though some were dendritic, and some of these also stained for IgG and light chains. This immunoglobulin had presumably been taken up from the surrounding tissue fluid. Hossfield et al. (1976) have reported cytogenetic abnormalities in lymphnode chromosome preparations from 2 patients with AIL. We have found cytogenetic abnormalities, with subpopulations bearing marker chromosomes, in the lymphnodes of the 3 patients from whom we obtained satisfactory preparations. There was no common feature shared by these cases, and it is difficult to know what interpretation to place on this observation. It would clearly be of interest to know whether the abnormalities are present in T cells, B cells or macrophages, and in future studies we will carry out our analyses on separated cell populations.
Of the 32 cases of AIL reported by Lukes and Tindle (1975) , 3 subsequently developed immunoblastic sarcomas. Donhuijsen et al. (1977) reported 3 patients with AIL terminating as malignant lymphomas, and noted that 13 such transitions have now been described. Malignant lymphoma developed in one of the patients in this series (RM). At postmortem the tumour showed widespread infiltration of heart and lungs, with relative sparing of the small residual lymphnodes. The histological appearance of the tumour was consistent with true histiocytic lymphoma, which was confirmed by the presence of phagocytosed 1061 material and positive cytoplasmic staining for muramidase and polyclonal immunoglobulins by the immunoperoxidase technique.
With the exception of one case of Hodgkin's disease (Yatanagas et al., 1977) all tumours previously described as terminations of AIL have been of B-cell lineage, possible occurring as a consequence of B-cell hyperstimulation and/or lack of T-cell regulatory function. The presence in our series of a tumour of histiocytic origin suggests that a more generalized disturbance of the immune system may underlie the termination of AIL in malignancy. It is possibly significant that 6 months after one of our patients (SH) presented with AIL his brother developed nodular sclerosing Hodgkin's disease.
The patients in this series who have died have all shown widespread intercurrent infection associated with a decline in all measured immunological parameters. Frizzera et al. (1975) similarly noted immunodeficiency with death from intercurrent infection in several of their patients, and they warned of the danger of hastening this process by treatment with immunosuppressive cytotoxic agents. This poses a therapeutic dilemma, since the only patients in this series who became long-term survivors were treated with cytotoxic drugs, and in none did we see more than a transient response to steroids. The infrequency of AIL makes it difficult for one centre to acquire enough experience to determine the optimal therapy for this condition, and there would appear to be a good case for instituting a national trial or for incorporating these patients into one of the existing lymphoma trials. The findings of this small series suggests that AIL can be divided into 2 immunopathological categories, and that these are associated with differences in clinical behaviour. It will be of interest to see whether further cases and larger series confirm these observations. 
